Europe Market Report for Orthopedic Navigation Systems 2017 - MedCore

Thursday, January 26, 2017 Research News J E 4

NEW YORK, Jan. 25, 2017 /PRNewswire/ -- General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends- Market Drivers & Limiters for each chapter segment- Competitive Analysis for each chapter segment- Section on recent mergers & acquisitionsUnlike the neurosurgery markets, navigation for orthopedics is not used as standard of care. There are many competing technologies in this market, such as patient-specific cut blocks, which also incorporate pre-operative imaging, as well as pressure sensors. Surgeons who have adopted navigation systems for orthopedics will keep using the system; however, that is only a percentage of total orthopedic surgeons. Surgeons who prefer other technology will argue that navigation systems are too cumbersome, too expensive and the added costs do not outweigh the benefits over the other technologies. However, due to the complexity of TKA and THA procedures there is still a need for this technology, but it has not been adopted universally. Many companies who were once very active in this market still manufacture their system but do not actively market and promote sales unless clients directly ask for upgrades. AbstractOrthopedic image guided surgery (IGS) systems are used in procedures such as total knee arthroplasty (TKA), total hip arthroplasty (THA), anterior cruciate ligament (ACL) reconstruction, trauma and corrective surgeries. During these reconstruction procedures, the alignment of the orthopedic implant is critical and IGS systems are capable of reaching the target alignment within +/- 3°, 95% to 98% of the time. Scope: 2013-2023

Read the full report: Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:

SOURCE Reportlinker



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Early Stage Drug Development in Oncology: Analytic...
PDE, PDA Introduce York Suburban School District S...